J P Morgan Chase & Co reaffirmed their neutral rating on shares of BTG plc (LON:BTG) in a research report sent to investors on Tuesday morning, StockTargetPrices.com reports. J P Morgan Chase & Co currently has a GBX 790 ($10.23) target price on the stock.
A number of other equities analysts have also recently issued reports on the company. Numis Securities Ltd reaffirmed a buy rating and issued a GBX 900 ($11.66) target price on shares of BTG plc in a report on Tuesday, April 25th. Panmure Gordon reaffirmed a buy rating and issued a GBX 737 ($9.55) target price on shares of BTG plc in a report on Thursday, April 20th. Investec reaffirmed a buy rating and issued a GBX 720 ($9.33) target price on shares of BTG plc in a report on Thursday, April 6th. Jefferies Group LLC reissued a buy rating and issued a GBX 775 ($10.04) price target on shares of BTG plc in a research note on Tuesday, May 16th. Finally, Stifel Nicolaus reissued a buy rating and issued a GBX 725 ($9.39) price target on shares of BTG plc in a research note on Tuesday, April 4th. Three equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The company currently has an average rating of Buy and a consensus target price of GBX 766.44 ($9.93).
BTG plc (LON:BTG) opened at 676.00 on Tuesday. BTG plc has a one year low of GBX 528.36 and a one year high of GBX 739.50. The firm’s 50-day moving average price is GBX 673.94 and its 200-day moving average price is GBX 613.59. The company’s market cap is GBX 2.60 billion.
TRADEMARK VIOLATION NOTICE: This report was originally published by WKRB News and is the sole property of of WKRB News. If you are accessing this report on another publication, it was stolen and republished in violation of United States & international copyright & trademark laws. The original version of this report can be viewed at https://www.wkrb13.com/markets/2284420/j-p-morgan-chase-co-reaffirms-neutral-rating-for-btg-plc-btg.html.
In other news, insider Rolf Soderstrom sold 22,624 shares of the stock in a transaction dated Friday, June 9th. The stock was sold at an average price of GBX 649 ($8.41), for a total value of £146,829.76 ($190,193.99).
About BTG plc
BTG plc is engaged in the business of healthcare, focusing on Interventional Medicine therapies for liver cancer, emphysema and vascular disorders, specialty pharmaceuticals for acute care uses, and a licensing business. The Company operates through three segments: Interventional Medicine, Specialty Pharmaceuticals and Licensing.
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2284420/j-p-morgan-chase-co-reaffirms-neutral-rating-for-btg-plc-btg.html
Receive News & Ratings for BTG plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BTG plc and related companies with MarketBeat.com's FREE daily email newsletter.